NervGen Pharma Provides a Corporate Update in Response to the COVID-19 Pandemic; Announces Upcoming Presentation at Solebury Trout Virtual Investor Conference on April 7th
Phase 1 Clinical Study Remains on Track for Q4 2020Vancouver, British Columbia--(Newsfile Corp. - April 6, 2020) - NervGen Pharma...